EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AstraZeneca (NASDAQ:AZN) Announces Earnings Results
AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr | Capital Market News - Business Standard
Earnings call: Innate Pharma Q3 2024 results highlight oncology pipeline By Investing.com
LBT Innovations Rebrands and Expands in Pharma Market
Kepler Capital Remains a Hold on AstraZeneca (AZN)
MQS Management LLC Has $832,000 Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Absci Corporation (NASDAQ:ABSI) Q3 2024 Earnings Call Transcript
AstraZeneca PLC (NASDAQ:AZN) Q3 2024 Earnings Call Transcript
Healthy Returns: AstraZeneca boosts U.S. investment on confidence in economy
AstraZeneca's (AZN) Robust Growth in China Despite Leadership Challenges
AstraZeneca Pharma India Q2FY25 results: Net profit falls 27% to Rs 38 cr | Company Results - Business Standard
AstraZeneca Investment: AstraZeneca announces $3.5 billion plan to expand U.S. R&D and manufacturing operations, ETPharma
AstraZeneca Q2 net profit declines 10%, revenue up 31%
CWA Asset Management Group LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (AZN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
AstraZeneca Reports Strong Growth in Q3 2024
Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the US for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results By Investing.com
Trending: AstraZeneca Expands Its Investment Plan in the U.S. | Morningstar
AstraZeneca Talks Up US Growth as China Problems Worsen
AstraZeneca lifts outlook as it doubles down on US growth
AstraZeneca invests $3.5 billion in US expansion By Investing.com
Wuxi's iCampus signs strategic cooperation with HK's health center and AstraZeneca - Chinadaily.com.cn
AstraZeneca PLC (NASDAQ:AZN) Given Consensus Recommendation of “Buy” by Analysts
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
Astra Invests $3.5 Billion in US as Cancer Drug Lifts Sales
AstraZeneca raises expectation for next year profits after Q3 performance | World News - Business Standard
City round-up; Franchise Brands; BAE Systems; Coral Products; Astra Zeneca; Convatec; McBride | TheBusinessDesk.com
AstraZeneca's 9M and Q3 2024 results By Investing.com
AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing | Markets Insider
AstraZeneca Raises Outlook on Earnings, Sales Beat | Morningstar
AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance
CREDIT UPDATE: AstraZeneca (AZN: A2 pos/A+/Au pos): 3Q24
AstraZeneca: Koselugo Phase III Trial Meets Primary Goal In Adults With Neurofibromatosis Type 1
AstraZeneca Q3 earnings beat estimates, raises full-year outlook By Investing.com
European markets fall as mining stocks slide; Bayer shares at 20-year lows; Mediobanca down 8%
AstraZeneca raises 2024 outlook on strong Q3 By Investing.com
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat By Reuters
)
AstraZeneca investing $3.5bn in R & D and manufacturing in the US
AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in US - November 12, 2024 - Zacks.com
Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer By Investing.com
AstraZeneca News | Markets Insider
Biliary Tract Cancer Market Size in the 7MM was ~USD 1000 million, is expected to grow by 2034, estimated DelveInsight
GDS Wealth Management Sells 448 Shares of AstraZeneca PLC (NASDAQ:AZN)
Buckingham Capital Management Inc. Sells 10,133 Shares of AstraZeneca PLC (NASDAQ:AZN)
Earnings To Watch: AstraZeneca PLC (OSTO:AZN) Reports Q3 2024 Result
Atria Investments Inc Buys 9,431 Shares of AstraZeneca PLC (NASDAQ:AZN)
ANGLE plc ("the Company") DNA ANALYSIS OF PARSORTIX-ENRICHE
Moving toward response-adapted trials in oncology
Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts? - November 11, 2024 - Zacks.com
Is AstraZeneca PLC (AZN) The Best UK Stock to Invest in Now?
SpiderRock Advisors LLC Buys 27,505 Shares of AstraZeneca PLC (NASDAQ:AZN)
Key Findings of the NIAGARA and HIMALAYA Trials
Sweden shares lower at close of trade; OMX Stockholm 30 down 1.01% By Investing.com
53,892 Shares in AstraZeneca PLC (NASDAQ:AZN) Bought by Summit Global Investments
Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2024 Earnings Call Transcript
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments | The Manila Times
South Africa: South Africa Becomes a Key Player in Astrazeneca’s Global Clinical Trial Success
Consolidated Planning Corp Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Sweden stocks lower at close of trade; OMX Stockholm 30 down 1.01% By Investing.com
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS | INN
Judge Denies AstraZeneca's Motion To Dismiss In Vaccine Injury Case | ZeroHedge
AstraZeneca ground-breaks new Antibody Drug Conjugate (ADC) Manufacturing Facility in Singapore
AstraZeneca (LON:AZN) Given Overweight Rating at JPMorgan Chase & Co.
AstraZeneca (AZN) Faces Investor Concerns Amid Executive Detention and Investigation
AstraZeneca PLC (NASDAQ:AZN) Given Consensus Rating of "Buy" by Analysts
News Highlights: Top Company News of the Day - Thursday at 1 AM ET | Morningstar
New AstraZeneca facility in Tuas South to create over 800 jobs, ready by 2029
Look ahead to FTSE 350, other companies reporting & economic events from 11 – 15 November 2024
Unveiling Astrazeneca (AZN) Q3 Outlook: Wall Street Estimates for Key Metrics - November 7, 2024 - Zacks.com
Ionis' Q3 Earnings and Revenues Beat Estimates, New Launches in Focus - November 7, 2024 - Zacks.com
AstraZeneca to build Antibody Drug Conjugate (ADC) Manufacturing Facility in Singapore
Earnings call: Cellectis reports robust cash reserves, new R&D initiatives By Investing.com
AstraZeneca’s China chief detained amid insurance probe
Harvest Portfolios Group Inc. Grows Holdings in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca shares plummet amid China investigation | Report.az
Hardman Johnston Global Advisors LLC Sells 9,801 Shares of AstraZeneca PLC (NASDAQ:AZN)
Deutsche Bank Aktiengesellschaft Upgrades AstraZeneca (NASDAQ:AZN) to Hold
Moloney Securities Asset Management LLC Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca commits to cooperting with China fraud probe after billions wiped from valuation By Proactive Investors
Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?
Ministry of Health in UAE partners with AstraZeneca to drive early lung cancer detection
Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings - November 6, 2024 - Zacks.com
World Street | Nvidia overtakes Apple, US stocks steady on election day, AstraZeneca hit by China probe, and more
AstraZeneca (NASDAQ:AZN) Shares Gap Down - Here's Why
AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca (AZN) Set to Announce Quarterly Earnings on Tuesday
CREDIT UPDATE: AstraZeneca (AZN: A2 pos / A+): China
AstraZeneca Down Over 8%, On Track for Largest Percent Decrease Since July 2023 — Data Talk | Morningstar
AstraZeneca Falls Most Since 2020 as China Probe Fears Escalate
Europe: Shares edge higher with US election in spotlight; AstraZeneca sinks
AstraZeneca Says Obesity Pill Well-Tolerated and Competitive (2)
Janney Montgomery Scott LLC Raises Stake in AstraZeneca PLC (NASDAQ:AZN)
Van ECK Associates Corp Purchases 67,002 Shares of AstraZeneca PLC (NASDAQ:AZN)
